A director at Crocs Inc bought 3,261 shares at 76.690USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
A director at Becton Dickinson & Co bought 5,250 shares at 191.570USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Moody's Ratings commented that Becton, Dickinson and Company's (BD, Baa2 stable) separation of its Biosciences and Diagnostic Solutions businesses through a Reverse Morris Trust (RMT) structure is credit negative. The transaction will reduce BD's scale and earnings while increasing its financial lev...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Crocs, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 13 December 2024 in which we reassessed the appropriateness of the ratings in the context of th...
Moody's Ratings (Moody's) commented that Becton, Dickinson and Company's (Baa2 stable) announcement that it had reached an agreement to resolve the vast majority of its US product liability lawsuits involving hernia repair devices is credit negative. Per the settlement terms, Becton will make paymen...
Moody's Ratings (Moody's) commented that Becton, Dickinson and Company's (Baa2 stable) announcement that it had reached an agreement to resolve the vast majority of its US product liability lawsuits involving hernia repair devices is credit negative. Per the settlement terms, Becton will make paymen...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.